Migdal Insurance & Financial Holdings Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

  • $6.25 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021
SELL
$62.15 - $90.32 $658,727 - $957,301
-10,599 Closed
0 $0
Q1 2021

May 04, 2021
BUY
$61.35 - $90.47 $403,498 - $595,021
6,577 Added 163.53%
10,599 $703,000
Q4 2020

Feb 08, 2021
BUY
$43.82 - $85.37 $176,244 - $343,358
4,022 New
4,022 $309,000

Others Institutions Holding ARWR

# of Institutions
296
Shares Held
88.5M
Call Options Held
905K
Put Options Held
387K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.71B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Migdal Insurance & Financial Holdings Ltd. Portfolio

Follow Migdal Insurance & Financial Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email